Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASP.L Regulatory News (ASP)

  • There is currently no data for ASP

Acquisition

22 Jun 2005 07:04

Ascribe plc22 June 2005 22 June 2005 Ascribe plc (Ascribe) makes further strategic acquisitions in medicines management IT The Board of Ascribe, the health IT group focusing on medicines management,announces today that it has further strengthened its market position inmedicines management IT by acquiring Park Systems Limited ("Park"), the largestindependent supplier of retail pharmacy computer systems in the UK, for amaximum consideration of £0.4 million. The consideration will be satisfied by amixture of cash and new ordinary shares. Park Systems was founded in 1981 and rapidly expanded to become one of today'sleading producers of high-quality, easy to use, retail pharmacy systemsincluding labelling, (EPoS - Electronic Point of Sale) and PMR (PatientMedication Records). The system is used in all aspects of retail pharmacythroughout the UK and worldwide. Significantly, Park's PMR equipment allowspharmacists to view a patient's historic and current medication records toensure that that they receive the correct prescriptions, much in the same way asAscribe's software solutions for hospital pharmacies through its subsidiary ASCComputer Software Limited ("ASC"). Following the completion of the acquisition, Liverpool-based Park Systems willimmediately move to Ascribe's Bolton Headquarters where it will merge with ASC.The Board anticipates that this will result in significant synergies for theenlarged division with the use of one software solution for both markets. For the year ended 31 March 2005, Park reported sales of £246,000 with a smallprofit. Commenting, Stephen Critchlow, Chief Executive of Ascribe, said: "Thisannouncement is a further example of how Ascribe continues to deliver on itsstated growth strategy of expanding the Company's business activities incomplementary areas of medicines management IT. Park is a successful, marketleading company in retail pharmacy solutions, which is a core component of theoverall market we address." In addition, Ascribe also announces today that it has acquired Archive Limited,a supplier of software to its Protechnic Exeter subsidiary for a maximumconsideration of £107,000. This follows the successful acquisition of Footman Walker on 23 May 2005, amarket leading supplier of clinical information systems into Accident &Emergency and minor injury units for £2.6 million. Contacts: Ascribe plc Tel: +44 (0) 161 280 8080 Stephen Critchlow Chief Executive Jeremy Lee Tel: +44 (0) 161 280 8080 Group Finance Director Citigate Dewe Rogerson Tel: +44 (0) 207 638 9571 Ginny Pulbrook Justin Griffiths Notes to Editors: Ascribe is a health IT group focusing on medicines management through thedevelopment and marketing of software solutions supporting patient, clinical andbusiness processes to the international healthcare market. The Group consistsof ASC Computer Software Limited, a software supplier to hospital pharmacydepartments internationally and Protechnic Exeter Limited, a provider ofsoftware solutions to the primary healthcare market. Ascribe joined AIM on 17December 2004 raising £5.5m before expenses. The software produced by Ascribe addresses the Audit Commission report 'ASpoonful of Sugar' published in 2001, which identified potentially up to 1,200lives and £500 million per year from certain medication errors in UK hospitalsalone could be saved using clinical information systems. Ascribe's systemenables pharmacists to store information about the patients they treat and usethis information to assist in their decision-making. The system also integrateswith stock control procedures. The latest web based product has further enabledtechnology to link the information between customers building a solution wherethe risk of the above medication errors can be reduced. Protechnic Exeter supports those who provide care within Primary Care,Community, Mental Health and Social Care. Its ePEX software is widely usedthroughout the United Kingdom and Ireland to provide specialist mental healthsystems to support the administration, clinical management and informationactivities of the Trusts; and child care systems for interactive scheduling forvaccinations, immunisations and surveillance, providing a longitudinal record ofpatients from birth into adulthood for all community services. Its Exetersoftware is widely used by UK GP practices. After considerable investment in web based solutions, the Group's strategy is touse this software to enhance its offering, initially to Protechnic Exetercustomers and then to customers of other acquisitions as they are completed andintegrated, delivering a Group capable of addressing the whole medicinesmanagement market. For further information, please visit: www.ascribe.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20219:49 amRNSUpdate on TIDM Code
1st Jun 20217:00 amRNSAdmission to Main Market
27th Jan 200911:45 amRNSPosting of re-registration circular
21st Jan 20097:30 amRNSOffer Unconditional in all Respects
8th Jan 20097:00 amRNSOffer update
7th Jan 20091:14 pmRNSHolding(s) in Company
5th Jan 20096:08 pmRNSGeneral Meeting & Recommended Cash Offer
18th Dec 20083:55 pmRNSAnnual Report and Accounts
17th Dec 20088:00 amRNSRecommended Cash Offer
10th Dec 200812:42 pmRNSResult of AGM
17th Nov 20087:00 amRNSDirector/PDMR Shareholding
10th Oct 200810:45 amRNSRule 8.3- Ascribe PLC
3rd Oct 200812:09 pmRNSRule 8.3- Ascribe PLC
1st Oct 20087:00 amRNSFinal Results
26th Sep 20087:00 amRNSAcquisition
3rd Sep 20089:06 amRNSExercise of Options
21st Aug 200811:39 amRNSRule 8.3- Ascribe Plc
19th Aug 20088:19 amRNSAnnouncement regarding possib
22nd Jul 20087:00 amRNSTrading Update
8th May 20087:01 amRNSASCC Framework Agreement
14th Apr 20084:29 pmRNSHolding(s) in Company
2nd Apr 20088:00 amRNSInstallement of Web Pharmacy
12th Mar 20087:01 amRNSInterim Results
15th Feb 20082:55 pmRNSIssue of Equity
4th Feb 20089:57 amRNSIssue of Equity
23rd Jan 20087:01 amRNSTrading Statement
21st Jan 20084:54 pmRNSIssue of Equity
7th Dec 200711:23 amRNSHolding(s) in Company
6th Dec 20075:28 pmRNSHolding(s) in Company
29th Nov 200711:29 amRNSDirector/PDMR Shareholding
31st Oct 200711:23 amRNSTrading update &Result of AGM
29th Oct 20073:24 pmRNSHolding(s) in Company
26th Oct 200711:29 amRNSHolding(s) in Company
25th Oct 20074:06 pmRNSDirector/PDMR Shareholding
25th Oct 200711:31 amRNSIssue of Equity
22nd Oct 20071:35 pmRNSIssue of Equity
22nd Oct 200712:40 pmRNSAcquisition
5th Oct 20079:09 amRNSHolding(s) in Company
25th Sep 20072:50 pmRNSHolding(s) in Company
19th Sep 20077:01 amRNSFinal Results
4th Sep 20077:00 amRNSNotice of Results
17th Aug 20075:30 pmRNSAIM Rule 26
17th Aug 20074:53 pmRNSAIM Rule 26 Information
15th Aug 20072:00 pmRNSHolding(s) in Company
9th Aug 20075:57 pmRNSHolding(s) in Company
30th Jul 20072:40 pmRNSIssue of Equity
24th Jul 20077:00 amRNSTrading Update
16th Jul 20075:19 pmRNSHolding(s) in Company
16th Jul 20077:00 amRNSDirectorate Change
8th Jun 20072:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.